CA2665818A1 - Composes therapeutiques - Google Patents

Composes therapeutiques Download PDF

Info

Publication number
CA2665818A1
CA2665818A1 CA002665818A CA2665818A CA2665818A1 CA 2665818 A1 CA2665818 A1 CA 2665818A1 CA 002665818 A CA002665818 A CA 002665818A CA 2665818 A CA2665818 A CA 2665818A CA 2665818 A1 CA2665818 A1 CA 2665818A1
Authority
CA
Canada
Prior art keywords
compound
independently
formula
nmr
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002665818A
Other languages
English (en)
Inventor
Edmond J. Lavoie
Joseph E. Rice
Leroy F. Liu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Medicine and Dentistry of New Jersey
Rutgers State University of New Jersey
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2665818A1 publication Critical patent/CA2665818A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/22Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/22Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains four or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D515/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D515/22Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains four or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
CA002665818A 2006-04-25 2007-04-24 Composes therapeutiques Abandoned CA2665818A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US79452506P 2006-04-25 2006-04-25
US60/794,525 2006-04-25
PCT/US2007/009862 WO2007127173A2 (fr) 2006-04-25 2007-04-24 Composés thérapeutiques

Publications (1)

Publication Number Publication Date
CA2665818A1 true CA2665818A1 (fr) 2007-11-08

Family

ID=38656126

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002665818A Abandoned CA2665818A1 (fr) 2006-04-25 2007-04-24 Composes therapeutiques

Country Status (3)

Country Link
EP (1) EP2079704A4 (fr)
CA (1) CA2665818A1 (fr)
WO (1) WO2007127173A2 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8093235B2 (en) 2006-04-25 2012-01-10 Rutgers, The State University Of New Jersey Macrocyclic compounds which stabilize G-Quadruplex DNA and RNA
JP2010535204A (ja) 2007-08-02 2010-11-18 ラトガーズ, ザ ステイト ユニバーシティ オブ ニュー ジャージー 治療用化合物
JP5476541B2 (ja) * 2008-06-25 2014-04-23 国立大学法人東京農工大学 テロメラーゼ阻害剤
CA2780145A1 (fr) 2009-11-05 2011-05-12 Rutgers, The State University Of New Jersey Composes therapeutiques
MX2013013863A (es) * 2011-05-26 2014-01-20 Novobiotic Pharmaceuticals Llc Antibioticos novedosos.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2517850A1 (fr) * 2003-03-04 2004-09-16 Sosei Co., Ltd. Agent de potentialisation a effet antitumoral contenant du gm-65, preparation antitumorale combinee et agent antitumoral
JP4876220B2 (ja) * 2005-05-13 2012-02-15 国立大学法人東京農工大学 テロメスタチン誘導体

Also Published As

Publication number Publication date
WO2007127173A4 (fr) 2009-02-05
WO2007127173A3 (fr) 2008-12-18
EP2079704A2 (fr) 2009-07-22
WO2007127173A2 (fr) 2007-11-08
EP2079704A4 (fr) 2011-11-16

Similar Documents

Publication Publication Date Title
JP3469580B2 (ja) 新規なペプチド誘導体
EP2593461B1 (fr) Composés destinés à réduire la production de bêta-amyloïde
US20090149526A1 (en) Tetracyclic Indole Derivatives as Antiviral Agents
WO1993004043A1 (fr) Agents anti-vih (sida)
HU211556A9 (en) Pyrroloindole derivatives related to dc-88a compound
EP2027125A1 (fr) Dérivés pentacycliques d'indole en tant qu'agents antiviraux
WO2004106343A2 (fr) Molecules et analogues de la famille agelastatine d'alkaloides antitumuraux et inhibiteurs de gsk-3?
CA2665818A1 (fr) Composes therapeutiques
JPH0826036B2 (ja) 生理活性物質k−252の誘導体
CS381891A3 (en) Benzodiazepinones
EP3782995A1 (fr) Inhibiteur d'histone acétyltransférase (hat) et utilisation associée
US8518928B2 (en) Therapeutic compounds
JP5325882B2 (ja) 治療用化合物
JPH08337584A (ja) 縮合六環式アミノ化合物、これを含有する医薬及びその製法
JPH05247055A (ja) スタウロスポリン誘導体及びそれを含有する抗腫瘍効果増強剤
EP0424802A2 (fr) Quinoléines tricycliques comme agents antinéoplastiques
EP2185568A2 (fr) Composés thérapeutiques
WO2000002864A1 (fr) Precurseur pour monomeres de pna
JPH0249788A (ja) ピラノベンゾオキサジアゾール誘導体
WO2013071027A1 (fr) Composés macrocycliques pour inhibition d'inhibiteurs de l'apoptose
JP6268656B2 (ja) ヒト免疫不全ウイルス複製の阻害剤
HU223948B1 (hu) Metotrexát-származékok, ilyeneket tartalmazó gyógyszerkészítmények és eljárás előállításukra
EP4303221A1 (fr) Nouveau composé alcaloïde de tétrahydroisoquinoléine contenant un macrocycle
Chiacchio et al. Recent advances in the synthesis of isoxazolidines
JP2001501213A (ja) スワインソニンの新規な3,5,および/または6置換された同族体、それらの製造方法および治療剤としてのそれらの使用

Legal Events

Date Code Title Description
EEER Examination request
FZDE Dead

Effective date: 20150210